Literature DB >> 8144921

Clustering of class I HLA molecules on the surfaces of activated and transformed human cells.

J Matko1, Y Bushkin, T Wei, M Edidin.   

Abstract

We surveyed cells for the clusters of class I HLA molecules, HLA-I, which we have previously found on JY lymphoblasts. Two fluorescence techniques, fluorescence resonance energy transfer and electron exchange quenching, detected clustered HLA-I molecules on activated normal B and T cells, on cells of B and T lymphoblast lines, and on transformed fibroblasts. No HLA-I clusters were detectable in the surfaces of resting B or T cells or normal fibroblasts. HLA clustering correlates perfectly with the presence of the HC-10 epitope of beta 2-microglobulin (beta 2m)-free heavy chains at the cell surface although not with the amount of this epitope expressed. Clustering was reversed by exogenous beta 2m, but this did not change the amount of HC-10 bound. This suggests that a form of beta 2m-free heavy chain in equilibrium with both native HLA molecules and fully denatured HC-10-positive heavy chains is involved in HLA-I cluster formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Function-related regulation of the stability of MHC proteins.

Authors:  A Simon; Z s Dosztányi; E Rajnavölgyi; I Simon
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Anomalous diffusion of major histocompatibility complex class I molecules on HeLa cells determined by single particle tracking.

Authors:  P R Smith; I E Morrison; K M Wilson; N Fernández; R J Cherry
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  Clustering class I MHC modulates sensitivity of T cell recognition.

Authors:  David R Fooksman; Gigi Kwik Grönvall; Qing Tang; Michael Edidin
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

4.  Measuring rotational diffusion of MHC class I on live cells by polarized FPR.

Authors:  David R Fooksman; Michael Edidin; B George Barisas
Journal:  Biophys Chem       Date:  2007-07-06       Impact factor: 2.352

5.  Measurement of two-dimensional binding constants between cell-bound major histocompatibility complex and immobilized antibodies with an acoustic biosensor.

Authors:  Michael Saitakis; Anastasia Dellaporta; Electra Gizeli
Journal:  Biophys J       Date:  2008-08-15       Impact factor: 4.033

6.  Analysis of cell surface molecular distributions and cellular signaling by flow cytometry.

Authors:  J Matkó; L Mátyus; J Szöllösi; L Bene; A Jenei; P Nagy; A Bodnár; S Damjanovich
Journal:  J Fluoresc       Date:  1994-12       Impact factor: 2.217

7.  Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts.

Authors:  G Vereb; J Matkó; G Vámosi; S M Ibrahim; E Magyar; S Varga; J Szöllosi; A Jenei; R Gáspár; T A Waldmann; S Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells.

Authors:  A Jenei; S Varga; L Bene; L Mátyus; A Bodnár; Z Bacsó; C Pieri; R Gáspár; T Farkas; S Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

9.  Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.

Authors:  Nadia Anikeeva; Tatiana Lebedeva; Aaron R Clapp; Ellen R Goldman; Michael L Dustin; Hedi Mattoussi; Yuri Sykulev
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

Review 10.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.